Article · 7 Apr 2026
ArticlePublished 2015
Interest of Botulinum Toxin for Treatment of Spasticity in Multiple Sclerosis
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Background: Pyramidal tract lesions are common in multiple sclerosis (MS) patients and cause symptoms of spasticity, weakness and paralysis. OnabotulinumtoxinA treatment for spasticity is well-recognised, but remains to be defined in MS. Objective: Analysis of practices in the treatment of spasticity in MS in a rehabilitation centre: Treatment of spasticity in MS with onabotulinumtoxinA according to level of disability. Methods: Retrospective patient data review was conducted on MS patients treated with onabotulinumtoxinA from 2007 to 2010 in our neurologic rehabilitation center, with the aim to assess the modalities of use and effectiveness of onabotulinumtoxinA injections in everyday clinical practice. Results: 126 patients (mean age: 49.4 ± 11 years), with a mean Expanded Disability Status Scale (EDSS) score of 5.8 ± 1.7 (range: 2.5-9.5) received onabotulinumtoxinA treatment. Key treatment goals were improved walking in the less disabled patients (mean EDSS: 5 ± 1), and improved comfort and nursing care for the most disabled patients (mean EDSS: 7.7 ± 1). Therapeutic benefit was assessed using a Visual Analogue Scale and results were 6 ± 2.5 and 6.3 ± 3, respectively, with repeat injections for 65% of patients Conclusion: OnabotulinumtoxinA used in daily practice seems to be an effective, well-tolerated treatment in MS, with goals that vary according to the level of disability: i.e., improved walking and patient comfort. Further studies are needed to define the place and the effectiveness of onabotulinumtoxinA treatment in MS.
Keywords
Subjects
Neuroscience & NeurologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Multiple Sclerosis.
Article · 12 Feb 2026
Demyelination: Understanding the Disruption of Nerve Function
Article · 12 Feb 2026
Brain Tumors: Insights into Diagnosis, Management, and Future Perspectives
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Multiple Sclerosis
- SubjectNeuroscience & Neurology
- BylineArticles whose byline prints “Gallien P”
- BylineArticles whose byline prints “Petrilli S”
- BylineArticles whose byline prints “Autret K”
- BylineArticles whose byline prints “Robineau S”
- BylineArticles whose byline prints “Le Meur C”
- BylineArticles whose byline prints “Berthier T”
- BylineArticles whose byline prints “A Durufle”
- BylineArticles whose byline prints “Houedakor J”
